Testosterone Replacement Therapy in Hypogonadal Men

被引：15
|
作者：
Wang, Christina [1 ]
Swerdloff, Ronald S. [2 ,3 ]
机构：
[1] Harbor UCLA Med Ctr, Lundquist Inst, Clin & Translat Sci Inst, Div Endocrinol, Torrance, CA 90502 USA
[2] Lundquist Inst, Div Endocrinol, 1124 West Carson St, Torrance, CA 90502 USA
[3] Harbor UCLA Med Ctr, 1124 West Carson St, Torrance, CA 90502 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2022年 / 51卷 / 01期
关键词：
Transdermal gels; Oral capsules; Intramuscular injections; Implants; Modified androgens; Selective androgen receptor modulators; Endogenous testosterone stimulators; HUMAN CHORIONIC-GONADOTROPIN; BONE-MINERAL DENSITY; ANDROGEN RECEPTOR MODULATORS; RANDOMIZED CLINICAL-TRIAL; HEALTHY ELDERLY-MEN; SERUM TESTOSTERONE; DOUBLE-BLIND; OLDER MEN; SEXUAL FUNCTION; DIMETHANDROLONE UNDECANOATE;
D O I：
10.1016/j.ecl.2021.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：77 / 98
页数：22
相关论文
共 50 条
  • [21] EFFECTS OF BASELINE TESTOSTERONE LEVELS ON SYMPTOM IMPROVEMENT IN HYPOGONADAL MEN RECEIVING TESTOSTERONE REPLACEMENT THERAPY
    Ni, X.
    Muram, D.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 240 - 241
  • [22] RACIAL DIFFERENCES IN HYPOGONADAL IMPROVEMENT AND PROSTATE SPECIFIC ANTIGEN IN HYPOGONADAL MEN TREATED WITH TESTOSTERONE REPLACEMENT THERAPY
    Coward, Robert M.
    Simhan, Jay
    Pruthi, Raj S.
    Carson, Culley C.
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 233 - 233
  • [23] THE UTILITY OF ALKALINE PHOSPHATASE AS A MARKER FOR RESPONSE TO TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL MEN
    Sheng, John
    Sapin, Ari
    Benson, Michael
    Sadeghi-Nejad, Hossein
    JOURNAL OF UROLOGY, 2017, 197 (04): : E465 - E465
  • [24] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Cipriano, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Taddei, S
    Salvetti, A
    JOURNAL OF HYPERTENSION, 2005, 23 : S211 - S211
  • [25] Testosterone Replacement Therapy Improves QTaVI in Hypogonadal Men with Spinal Cord Injury
    La Fountaine, Michael F.
    Wecht, Jill M.
    Cirnigliaro, Christopher M.
    Kirshblum, Steven C.
    Spungen, Ann M.
    Bauman, William A.
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 341 - 346
  • [26] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Cipriano, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Taddei, S
    Salvetti, A
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 177A - 177A
  • [27] TESTOSTERONE REPLACEMENT THERAPY IN OPIOID-INDUCED HYPOGONADAL MEN: A PROSPECTIVE ANALYSIS
    Sisul, D.
    Acevedo, J.
    Raheem, O.
    Hsieh, T.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 119 - 120
  • [28] Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy
    Bernini, G
    Versari, D
    Moretti, A
    Virdis, A
    Ghiadoni, L
    Bardini, M
    Taurino, C
    Canale, D
    Taddei, S
    Salvetti, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (05): : 1691 - 1697
  • [29] TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL MEN UNDERGOING ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Berookhim, B.
    Krishnan, R.
    Nelson, C. J.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 147 - 148
  • [30] Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men
    Angelova, Petya
    Momchilova, Albena
    Petkova, Diana
    Staneva, Galya
    Pankov, Roumen
    Kamenov, Zdravko
    AGING MALE, 2012, 15 (03): : 173 - 179
12345